Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SaiLuoTong in Vascular Dementia
NCT01978730Phase 2Unknown
- Sponsor
- China Shenwei Pharmaceutical Group
- Start
- Dec 2011
- Primary completion
- Jul 2014
- Modality
- HM (Herbal Medicine), Combination Drug
- Countries
- 1
01
Overview
A Phase 2 trial of sailuotong in vascular dementia, sponsored by China Shenwei Pharmaceutical Group. Status: unknown.
02
Drugs
sailuotong
03
Conditions
vascular dementia
Beyond the preview
Go deeper on NCT01978730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01978730.